Comparing physician-specific two-year patient outcomes after coronary angiography Methodologic issues and results by Ellis, Stephen G et al.
Comparing Physician-Specific Two-Year
Patient Outcomes After Coronary Angiography
Methodologic Issues and Results
Stephen G. Ellis, MD, FACC,* Dave Miller, MS,§ Thomas F. Keys, MD,†‡ Kimberly Brown, RN,*
Renee Ellert, RN,* Georgiana Howell,* A. Michael Lincoff, MD, FACC,* Eric J. Topol, MD, FACC*
Cleveland, Ohio, and San Francisco, California
OBJECTIVES We sought to evaluate methodologies to compare physician-related long-term patient
outcomes appropriately.
BACKGROUND Evaluation of physicians on the basis of short-term patient outcome is becoming widely
practiced. These analyses fail to consider the importance of long-term outcome, and methods
appropriate to such an analysis are poorly defined.
METHODS All patients undergoing coronary angiography between 1992 and 1994 who received all of
their cardiac care at our institution were followed for 27 6 13 months (mean 6 SD). Patients
(n 5 754) were cared for by one or more of 17 staff physicians. Risk-adjusted models were
developed for four candidate clinical end points and cost. Physicians were then evaluated for
each outcome measure.
RESULTS Of the clinical end points, death could be modeled most accurately (c-statistic 5 0.83). The
c-statistics for other end points ranged from 0.63 to 0.70. Physicians with outcomes
statistically different (p , 0.05) from other physicians were identified more commonly than
would be expected from the play of chance (p 5 0.005). However, improvement in the
c-statistics by the addition of physician identifiers was very modest. Physician’s evaluations by
the four measures of clinical outcome were variably correlated (r 5 .00 to .85). Graphic
display of clinical and cost results for each physician did identify certain physicians who might
be judged to provide more cost-effective care than others.
CONCLUSIONS Although comparisons of groups of physicians on the basis of long-term patient outcomes
may have merit, individual physician-to-physician comparisons will be more difficult, owing
to 1) multiple physicians contributing care to individual patients; 2) the poor predictive
capacity of models other than that for survival; and 3) the modest apparent impact of
differences in physician providers on long-term patient outcome. With these caveats in mind,
modeling to compare patient outcomes of individual physicians with homogeneous patient
populations or to identify gross outliers (good or bad) may be practicable in some patient-care
systems, but may be inappropriate in others. (J Am Coll Cardiol 1999;33:1278–85) © 1999
by the American College of Cardiology
Although controversial in both concept and execution,
evaluation in public forums of high-profile medical special-
ists such as cardiac surgeons and invasive cardiologists is
currently being practiced by comparison of their physician-
specific patient outcomes (1). Although debated, a public
health benefit of such analyses has been claimed by the State
of New York because short-term mortality associated with
CABG (coronary artery bypass graft) surgery appears to have
decreased since public dissemination of results began in 1991
(2). Present analyses focus on short-term results, and might
penalize, for example, physicians who accept high-risk patients
for coronary revascularization. Methodologies appropriate
to compare long-term outcomes remain poorly developed.
We analyzed several methods of assessing physician-
specific patient outcomes (adverse clinical events and cost)
in a well-characterized cohort of 754 patients receiving all
their cardiac care in our medical system over a period of
27 6 13 months.
METHODS
Patient population. All patients undergoing coronary an-
giography from January 1, 1992, through December 31,
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1994, who responded to query that they expected to or were
receiving all cardiac care at our institution, and who con-
sented to participate in a study tracking cardiac cost and
clinical outcome over time (3), were included in this study
(most patients undergoing catheterization at our institution
receive their primary care elsewhere). Baseline, treatment,
in-hospital clinical outcome and all cost data were recorded
prospectively in several hospital databases that were merged
for the purposes of this and the above-mentioned cost study
(3). Long-term clinical follow-up was obtained via chart
review and phone contact, as described previously (3). If the
patient was alive and exited our care system, patient data
were censored at the time of exit. Patients having had or
awaiting cardiac transplantation were excluded.
Responsible physician(s). In our clinic system, patients
were typically assigned to one primary cardiologist, who
then, as necessary, referred them to another cardiologist for
specific procedures. Physicians included in this analysis
would be categorized as generalist cardiologists who also
performed cardiac catheterization, some of whom were also
specialists in percutaneous coronary intervention (PCI),
intensive care unit cardiology, or treatment of patients with
congestive heart failure (CHF) (not mutually exclusive).
Over time, however, the patient’s primary cardiologist
might change. When the primary cardiologist at the time of
the catheterization and the current cardiologist were the
same physician, they were assigned responsibility for the
patient’s outcome. When the physicians were different,
responsibility was assigned two ways: 1) the initial cardiol-
ogist alone (primary cardiologist), 2) the initial and subse-
quent cardiologist shared responsibility equally (co-primary
cardiologist). Both methods of assignment were evaluated as
possible methods for optimal “scorecarding.”
Method of determining cost. In-hospital and outpatient
cardiac and cardiac-related (i.e., those related to complica-
tions of cardiac procedures) costs (laboratory tests, medica-
tions, physician visits) were obtained using a commercially
available cost-accounting system (Transition System, Bos-
ton, Massachusetts) and previously described methodology
(3,4).
Variables and definitions. Modeling of clinical outcome
and cost was performed using the following baseline vari-
ables:
Angiographic: jeopardy score (an estimate of the amount
of left ventricular myocardium at risk; scored 0–6)
(5); left ventricular systolic function (0 5 normal, 1 5
mild dysfunction [EF 5 45 to 55%], 2 5 moderate
dysfunction [EF 5 30 to 44%] and 3 5 severe
dysfunction [EF , 30%] by ventriculography or
echocardiography); number of diseased vessels ($50%
diameter stenosis of a bypassable vessel from one or
more of three major vascular territories).
Clinical: age, aortic valve disease (valve area ,1.2 cm2,
$21 regurgitation, or equivalent), Canadian Cardio-
vascular Association angina class, cardiogenic shock,
catheterization status (elective, urgent [requiring
catheterization within 24 h of referral], or emergency
[requiring immediate catheterization]), COPD
(chronic obstructive pulmonary disease) requiring
treatment, creatinine $2 mg/dl, current smoking,
gender, history of ventricular tachycardia or fibrilla-
tion, height, hospital transfer, hypertension (systolic
$180 mm Hg, diastolic $100 mm Hg or treated),
insulin-requiring diabetes, mitral valve disease (valve
area ,2.0 cm2, $21 regurgitation, or equivalent),
New York Heart Association CHF class, non-
insulin-requiring diabetes, number of major co-
morbidities (COPD, creatinine $2 mg%, stroke or
TIA [transient ischemic attack], PVOD [peripheral
vascular obstructive disease]), pacemaker, positive
stress test, prior CABG, prior MI (myocardial infarc-
tion), prior PCI, prior stroke or transient ischemic
attack (TIA), race, recent MI (within 2 weeks), renal
insufficiency requiring dialysis, stable angina, symp-
tomatic PVOD (peripheral vascular obstructive dis-
ease), unstable angina, and weight.
Statistical analyses. All data, except for cost data, which
are presented as median and interquartile range owing to
their non-Gaussian distribution, are presented as mean 6 1
SD. Survival analyses were performed using Kaplan-Meier
and Cox analyses. Models were developed using 35 poten-
tial clinical and anatomic covariates to predict the five major
candidate end points of this study: survival; MI-free sur-
vival; event (death, MI, CABG, PCI)-free survival; severe
angina and event-free survival; and cost. Creatinine kinase
(CK) levels were obtained routinely at 8 and 24 h after PCI,
and in the event of suspected ischemia. Myocardial infarc-
tion was defined as development of new pathologic Q waves
on electrocardiogram (ECG) or CK . 23 normal (with
elevated MB fraction) under most circumstances, $33 after
PCI, and $53 after CABG. The accuracy for each model
in predicting outcome was assessed using regression analysis
and receiver operating characteristic modified for survival
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft (surgery)
CAD 5 coronary artery disease
CHF 5 congestive heart failure
CK 5 creatine kinase
COPD 5 chronic obstructive pulmonary disease
MI 5 myocardial infarction
PCI 5 percutaneous coronary intervention
PVOD 5 peripheral vascular obstructive disease
ROC 5 receiver operating characteristics
TIA 5 transient ischemic (cerebrovascular) attack
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analysis as described by Harrell et al. (6). Models were
internally validated 10 times using a randomly selected 80%
sample for fitting and the remaining 20% of the sample for
testing in order to determine the extent to which the
predictive accuracy of the models was overly optimistic (7).
Models were internally calibrated by comparing actual to
predicted outcomes for patient-risk quintiles based upon
predicted outcome.
To these models were then added physician-specific
identifiers to ascertain the effect of each physician(s) caring
for the patient on the various outcomes. All physicians with
20 or more patients in this cohort were evaluated. Two
separate analyses were performed—one using the cardiolo-
gist caring for the patient at the time of the catheterization,
and the other linking both that physician and the primary
cardiologist during follow-up to the patient and their
outcome. Physicians were then ranked by their beta coeffi-
cient of the variable reflecting provider care. Physicians with
risk-adjusted patient outcomes significantly better or worse
(p # 0.05) than other physicians were considered “outliers.”
Physician coefficients for each of the five outcomes and two
methods of assigning outcome responsibility were then
compared using standard regression techniques.
In addition, graphical depiction of the relation between
providers’ clinical and cost results was presented, using their
individual correlation coefficient and its standard deviation
for each parameter to develop plots in a two-dimensional
grid.
To assess the subjectivity and potential for manipulation
of data (8) of several potential end points and covariates, 11
cardiologists, epidemiologists, or statisticians familiar with
management of patients with coronary artery disease were
asked to grade each parameter on a 1–5 scale (1 5 highly
objective; 5 5 highly subjective). These data were used to
place the objectivity of parameters involved in “scorecard-
ing” into perspective, but not for the modeling process
per se.
RESULTS
Long-term follow-up. The average time of clinical
follow-up in survivors was 27 6 13 months. Ten patients
(1.3%) were lost to follow-up and 69 patients (8.8%) left the
clinic system for another medical care group at 23 6 10
months. Patients leaving the clinic system less often had
baseline creatinine $2.0 mg% (1.6% vs. 6.9%, p 5 0.007)
and CHF (4.3% vs. 10.6%, p 5 0.02), but were otherwise
similar to patients remaining in the system. Cost and
clinical outcome data through 12 months, when most
patients who eventually left were still in the system, were
nearly identical for those who eventually left and those who
did not.
Baseline characteristics, initial treatment and outcome.
MEDICAL THERAPY. After catheterization, 337 patients
were referred for medical therapy (see Table 1). Of these,
243 had significant CAD. Their survival at 30 days, 1 year,
and 2 years was 98.0 6 0.9%, 94.0 6 1.6%, and 88.1 6
2.5%, respectively. Their event-free survival at these same
time milestones was 97.1 6 1.1%, 85.3 6 2.3%, and 71.2 6
3.5%, respectively. After two years, 82% had no angina, 14%
had class I–II angina and 4% had class III–IV angina. In
addition, 5 patients had primary ventricular arrhythmias, 4
patients had primary valvular heart disease, 4 patients had
coronary spasm and 81 patients had suspected but no
significant CAD. The overall median two-year per patient
cardiac cost of care for patients initially referred for medical
therapy alone was $9,386 ($14,411 for those with demon-
strated CAD).
PERCUTANEOUS INTERVENTION. Two hundred thirty-two
patients were referred for a PCI as their initial treatment
after the index catheterization (see Table 1). The primary
device used was balloon angioplasty in 68.6%, stent in
12.3%, directional atherectomy in 10.6%, rotational
atherectomy in 6.8% and excimer laser in 1.7%. Technical
success without death, infarction or need for CABG was
obtained in 94.5% of patients. Overall survival and event-
free survival at 30 days, 1 year, and 2 years was 98.7 6 0.7%,
97.8 6 1.0%, 95.1 6 1.6%, and 91.8 6 1.8%, 65.2 6 3.2%,
60.4 6 3.4%, respectively. After two years, 86% had no
angina, 12% had class I–II angina and 1% had class III–IV
angina. Their cumulative cost of cardiac care at 2 years was
$23,514.
BYPASS SURGERY. One hundred eighty-five patients had
CABG as their initial therapy after catheterization (see
Table 1). Seventy-one percent received one or more arterial
conduits and 10% had concomitant valve surgery. Their
survival and event-free survival at 30 days, 1 year, and 2
years was 97.3 6 1.2%, 93.3 6 1.9%, 91.9 6 2.1% and
91.3 6 2.1%, 83.3 6 2.8%, 81.2 6 3.0% respectively. After
2 years, 88% had no angina, 9% had class I–II angina and
3% had class III–IV angina. Their cumulative cost of cardiac
care at 2 years was $35,544.
Physician providers. Of the 17 physician providers, all
performed cardiac catheterization, and 9, 3, and 3 also
subspecialized in PCI, CHF, and intensive care cardiology,
respectively. The mean number of patients cared for in a
primary fashion for this group was 45 6 25 (median 5 47).
Reliability of variable coding. The results of the physician
panel assessment of the subjectivity or susceptibility of
selected candidate covariates and end points to manipula-
tion are shown in Figure 1. Some variables such as death
and CABG were judged to be objective and reliably deter-
mined. Conversely, other variables such as CHF class,
catheterization status (elective/urgent/emergency) and un-
stable angina were considered to be rather unreliable owing
to either subjectivity or susceptibility to manipulation.
Modeling candidate end points. The variables correlated
with selected candidate end points, their contribution to
potential models, predictive accuracy and calibration of the
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models are shown in Table 2 and 3 and Figure 2. Of the
clinical models, that for overall survival was considerably
most predictive (c-statistic or area under ROC [receiver
operating characteristic] curve, 0.83). C-statistics for the
models for MI-free survival and angina/event-free survival
were 0.63 and 0.70, respectively (data not shown). Consid-
ering that only variables available immediately after cathe-
terization were used for these predictive models, the model
for loge cost was also quite predictive (r 5 0.57).
Identifying physician outliers. Acknowledging that our
power to detect significant (p , 0.05) outliers was low
because of relatively few patients for each provider, the
frequency of identifications of outliers (n 5 34 possible,
counting primary and co-primary status separately) for
various models was as follows: survival, 5.9%; MI-free
survival, 20.6%; event-free survival, 5.9%; angina and event-
free survival, 2.9%; cost, 17.6%. Thus, the likelihood that
the identification of outliers for all outcomes combined was
purely by chance was very low [expected 5 34 physicians per
each of 5 models/one divided by mean p value for each
outlier (0.029) 5 170/34 5 5.0; observed 5 18, x2 5 7.88,
p 5 0.005].
Figure 1. Subjectivity of selected candidate covariates and end
points. Point estimates and 95% confidence limits for selected
variables (1 5 most objective; 5 5 most subjective) are shown.
CABG in this figure refers to CABG as a complication of PCI.
Table 1. Baseline Patient Characteristics (by Treatment Group)
Study Cohort
All Patients Undergoing
Catheterization 1992–94Medicine* PCI CABG Total
Number 337 232 185 754 14,622
Age (yrs) 65 6 11 64 6 10 66 6 10 65 6 10 62 6 11
Angina class
I–II (%) 51 48 42 48 NA*
III–IV (%) 26 40 38 33 NA
Catheterization status
Emergency (%) 2.0 10.7 7.0 5.8 NA
Urgent (%) 29.9 35.9 48.1 35.8 NA
Current smoker (%) 16 17 21 17 22
Diabetes (%) 28 26 33 29 29
Hypertension (%) 67 60 71 66 62
Male (%) 67 77 72 71 70
Major comorbidities
COPD (%) 5 7 7 6 6
Creatinine $2 (%) 8 4 2 6 5
CVA/TIA (%) 12 8 14 11 10
PVOD (%) 18 17 19 18 19
Prior CABG (%) 31 25 20 27 25
Prior MI (%) 45 40 42 43 43
Prior VT/VF (%) 7 4 3 5 NA
LVEF , 40% (%) 13 12 11 12 15
Multivessel disease (%) 29 37 89 45 52
Jeopardy score (0–6) 1.3 6 1.5 2.3 6 1.3 3.8 6 1.4 2.2 6 1.7 NA
Unstable angina (%) 44 49 49 47 NA
Hospital transfer (%) 9 17 17 13 NA
*During the time period studied, prospective data accrual for all patients undergoing catheterization was not performed, but rather selected data variables were captured by a
trained group of individuals after chart review.
CABG 5 coronary artery bypass graft (surgery); COPD 5 chronic obstructive pulmonary disease; CVA 5 cerebral vascular accident (stroke); PVOD 5 peripheral vascular
obstructive disease; TIA 5 transient (cerebral) ischemic attack; VT/VF 5 ventricular tachycardia or fibrillation.
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Correlation of physician evaluation between different
models. Pearson linear regression coefficients (r) showing
the relationship of the physicians’ evaluations between each
of the models are provided in Table 4 (see methodology).
Assessment of physician contribution, as primary or
co-primary, by linear regression between the two revealed
very good agreement (r . .90) for all models except
event-free survival (r 5 .86) and angina and event-free
survival (r 5 .63). Evaluation by models characterizing
largely overlapping end points (e.g., event-free survival and
angina and event-free survival) correlated well (r 5 .85),
whereas the correlation between most other clinical models
was weak (r # .40). Physician evaluation on the basis of cost
was reasonably well correlated with that for survival (r 5 .63
to .66), and modestly well with event-free and angina and
event-free survival (r 5 .33 to .54), but poorly with the
results of the models of MI-free survival (r 5 .00 to .17).
Influence of physician modeling on models’ correlation
with outcome. In general, the increment in correlation
gained by adding physician identifiers to the clinical vari-
ables was very modest. Co-primary physician identifiers
were somewhat more helpful than were primary physician
identifiers. For example, for the end point of long-term
survival, inclusion of primary physician identifiers resulted
in a c-statistic of 0.831 (baseline without physician identi-
fiers, c 5 0.829), whereas co-primary physician identifier
inclusion yielded a c-statistic of 0.833. The c-statistic for
physician identifiers alone was 0.648. For the end point of
event-free survival addition of the primary physician iden-
tifier increased the c-statistic from 0.672 to 0.685. For
2-year log cost, the inclusion of primary physician identifiers
resulted in a variance (r2 5 .332) (baseline r2 5 .326),
whereas co-primary physician identifier inclusion yielded a
r2 5 .342. The variance accounted for by the physician
identifiers alone was 0.063.
Model bias favoring different subspecialty groups. One
potential bias was identified when codes for subspecialty
groups were entered into each of the five models—for
MI-free survival, intensive care physicians had worse out-
comes (p 5 .005). With no other model could a bias for or
against any physician group be identified.
“Global” evaluation of individual physician performance.
Given the superior performance of our survival and cost
models, one may succinctly characterize each individual
physician’s patient outcomes by bipolar graphing the phy-
sician’s coefficient and its 95% confidence limits for these
two models (for examples, see Fig. 3).
DISCUSSION
Although quantitative assessment of physician-specific out-
comes is being increasingly practiced, several limitations
have been identified: 1) the somewhat limited accuracy and
concordance of potential models (8,9); 2) the common
imprecision of point estimates of patient risk owing to the
generally low volume of physician-specific outcomes from
which to judge results (8); 3) the susceptibility of potential
covariates and end points to manipulation (8); 4) the
potential risk inherent in publicizing such results wherein
high-risk patients might be declined therapy (10); and 5)
the failure of such models to account for the long-term
outcome of interventions.
Table 2. Independent Baseline Characteristics Correlated With Survival
Covariate Estimate SD T-stat p
Dialysis 3.30 0.59 5.54 , .001
Age/10 yrs 0.94 0.20 4.74 , .001
Diabetes requiring insulin 1.44 0.32 4.55 , .001
Left ventricular function 0.13 0.03 3.55 , .001
Caucasian race 21.11 0.38 22.94 .003
NYHA CHF class 0.39/unit 0.14 2.81 .005
Prior CABG 0.70 0.28 2.50 .013
Urgent catheterization 20.66 0.30 22.18 .029
Congestive heart failure 0.76 0.35 2.14 .032
Final log-likelihood 5 2280.29, p , 0.0001. ROC c-statistic 5 0.829. CABG 5 coronary artery bypass graft (surgery); CHF 5
congestive heart failure; NYHA 5 New York Heart Association.
Table 3. Independent Baseline Correlates of Event-Free Survival
Covariate Estimate SD 95% CI T-stat p
CAD 2.28 .58 1.14/3.43 13.90 , .001
NYHA CHF Class 0.23 .07 .09/.38 13.11 .002
Stable angina 0.53 .18 .17/.89 12.87 .004
Creatinine $2 0.55 .29 2.02/1.12 11.88 .064
Log likelihood 5 21031.499. ROC c-statistic 5 0.672. CAD 5 coronary artery disease; CHF 5 congestive heart failure;
NYHA 5 New York Heart Association.
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Our results extend these observations, specifically focus-
ing on long-term outcomes. In attempting to evaluate such
outcomes, it is apparent that the first three limitations noted
above pose similar problems as in short-term analyses. In
addition, we identify several problems specific to the anal-
ysis of long-term patient outcome: First, over longer periods
of patient follow-up, the responsible physician or physicians
may change and it may be difficult to define how one or
more physicians should be held “accountable” for the patient
outcome. In addition to changing physician providers, when
the patient changes provider systems it becomes increasingly
difficult to capture all patient-related costs, such that at-
tempts at deriving estimates of cost-effectiveness of care may
be problematic. Second, at least as studied in this somewhat
homogeneous treatment setting, the physician provider(s)
may have only a very modest impact on long-term patient
outcome, relative to the patients’ “baseline” clinical state.
Third, models emphasizing the importance of certain out-
comes may preferentially identify certain types of physicians
as having good or poor outcomes. Nonetheless, use of the
best models of this analysis, those for mortality and cost,
may provide a reasonable estimate of the cost-effectiveness
of care rendered by different providers.
It is axiomatic in biostatistics that unless the physiologic
causes of different end points are congruent, that the
predictive accuracy of models assessing composite end
points will be less accurate than those assessing single end
points (assuming comparably powered analyses). Thus, it is
not surprising in this analysis that the model for the clinical
end point death was the most accurate (c-statistic 5 0.83).
However, as the capacity to identify physician outliers is
directly related to the number of adverse events, composite
models are somewhat more likely to allow identification of
providers with either good or poor outcome. Nonetheless,
Figure 2. Calibration of the models for (A) long-term survival and
(B) long-term loge cost. Patients were divided into quintiles based
upon predicted outcome; actual and predicted values are shown for
each quintile.
Table 4. Correlation Matrix (R) for Physician Outcomes*
Coefficients for Outcomes 1* 2 3 4 5 6 7 8 9 10
1) Survival–primary .99 .23 .12 .12 .16 .03 .10 .66 .64
2) Survival–co-primary — — .18 .03 .04 .15 .09 .08 .67 .63
3) Infarct-free survival–primary — — — .91 .22 .11 .23 .02 .00 .05
4) Infarct-free survival–co-primary — — — — .28 .07 .40 .02 .16 .07
5) Event-free survival–primary — — — — — .86 .85 .79 .43 .33
6) Event-free survival–co-primary — — — — — — .57 .85 .39 .35
7) Angina and event-free survival–primary — — — — — — — .63 .48 .39
8) Angina and event-free survival–co-primary — — — — — — — — .54 .54
9) Cost–primary — — — — — — — — — .96
10) Cost–co-primary — — — — — — — — — —
*1 5 Survival–primary (numbers across the top refer to numbering system used along the first column).
Figure 3. Two-dimensional graphic representation of three se-
lected physician-specific outcomes for relative risk of long-term
death and the relative risk of long-term log cost. Point estimates
and 95% confidence limits are shown.
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one must be concerned about the limited capacity of other
models to adjust for patient characteristics that might bias
measures of outcome. Thus, as with our analyses or short-
term outcomes, the capacity to identify physician outliers
becomes highly dependent on the number of procedures or
patients that can be analyzed (8).
As with models assessing short-term provider outcome,
models assessing long-term outcome may be susceptible to
“gaming” (8). Such “code creep” has been identified in
longitudinal analyses of the New York State database
assessing the results of bypass surgery (1). For our model of
long-term survival (Table 2), the covariates assessing CHF
status and the urgency of cardiac catheterization, in partic-
ular, were noted to be moderately subjective (see Fig. 1).
The other elements that were evaluated would be consid-
ered rather objective. The covariates of the other models
analyzed were no more, and sometimes less, objective (8).
Thus, to have credible data for optimal physician-specific
outcome measurement, some form of external auditing must
be developed.
Even with a fee-for-service system of medical care, it is
not unusual for a patient with a chronic disease managed
over several years to have several physicians who have direct
and major input into management decisions that influence
outcome. To hold only one of these physicians responsible
for the patient’s outcome might be inappropriate. There are
no accepted standards of “weighting” the input of various
physicians. On the one hand, one might argue that the
physician performing a procedure should be held account-
able for the results. On the other hand, the physician
referring that patient for the procedure would then bear no
responsibility for either good or bad outcome. As the United
States moves toward the more common use of a managed-
care medical system, the identification of one or even a few
providers to be held accountable for the patient outcome
becomes more problematic. Therefore, it may be much
more reasonable to attempt to compare the results of
different management systems against one another rather
than the results of the individual physicians in those
managed-care systems. However, as such systems are made
up of individual physicians, it would still be very desirable to
identify physicians who have both good and bad outcomes
within the systems.
Comparison of provider-related outcomes would be most
simple if a single robust model could be used for large
groups of patients such as those with CAD. The analyses
described herein identify the limitations of such an ap-
proach. Patients who had undergone or were awaiting
cardiac transplantation were eliminated a priori so as not to
bias the model’s results against the physicians caring for
these patients. Even after this, certain potential models,
such as that for MI-free survival, appeared to be biased in
favor or against cardiologists who subspecialized in different
facets of cardiology. The study was likely underpowered to
detect differences between subspecialty groups regarding
long-term patient survival. One might argue that disease-
status-specific models (e.g., CAD with CHF) might best be
applied, but the logistics of applying this in a practical sense
could be quite cumbersome. An alternative, and perhaps
more reasonable approach, might be to eliminate from the
analysis certain groups of patients who are generally ac-
knowledged to be at particularly high risk—such as trans-
plant patients or patients in cardiogenic shock.
For chronic diseases typified by recurrent symptoms it is
generally acknowledged that measures of cost-effectiveness
using mortality as the only end point have serious limita-
tions (11). Yet standardized measures of quality of care have
not been widely measured in clinical practice, and authori-
ties debate the optimal measure for disease-specific entities
(12). Hence, our capacity to judge clinical cost-effectiveness
for chronic diseases on a widespread basis necessary for
evaluation of large numbers of providers is problematic.
Further complicating such an evaluation is the above-noted
limited accuracy of many models, patient migration between
provider systems, and also lack of standardized statistical
methodology necessary to compare, for instance, the accu-
racy and utility of models with ranked categorical outcome
and those with single-end point time-dependent variables.
From this analysis it would appear that evaluation on the
basis of mortality and cost in this setting would be the most
reliable and acceptable measure, acknowledging the fact that
our capacity to identify outliers might be more limited than
with other modeled end points.
Finally, it is of very considerable interest to note that
physicians whose patients tended to have the best clinical
outcomes also had the lowest costs. Although it is now well
recognized that complications drive up short-term costs in
several settings (13), the concern has also been raised that
attempts to decrease costs will attenuate the quality of
patient care. In the present study, we were unable to
demonstrate any evidence of this latter concern.
Study limitations. In reviewing the results of this analysis,
it is important to take notice of several limitations. First, the
data are derived from a somewhat unique cohort of patients
from a single tertiary referral center. The extent to which
they can be generalized into other settings must be tested.
Identification of differences in provider-related outcomes
might be more readily achieved in more heterogeneous
settings(s) (14–17). The identification of key clinical vari-
ables influencing outcome and other methodological issues
should not be influenced nearly as much by this issue.
Second, the extent to which a physician may actually
influence long-term patient outcome is not known. Third, a
rather limited number of patients and providers were
studied—it is quite likely that in a larger study, other
findings not apparent here might become manifest.
Finally, given the large number of statistical tests per-
formed evaluating each physician provider, a p value on the
order of .01 to .05 on a single test should not be viewed as
conclusive evidence that the physician is an outlier. None-
theless, the findings reported herein may serve as initial
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guidelines by which physicians and physician-care groups be
evaluated and, perhaps more importantly, stimulate further
research in this still-nacient field.
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